Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Taxol Exclusivity Continues, Thanks To ABI Cremophor-Free Patent

Related Content

Bristol To Focus On Paraplatin For Oncology Growth; UFT Review Delayed

Mar 13 2000

Pfizer Sees Neurontin Exclusivity Through 2002, Pregabalin Filing By Year-End

Jul 31 2000

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window